Research ExplorerPublicationsHealth-related quality of life and patient-defined benefit o...

Health-related quality of life and patient-defined benefit of clobetasol 0.05% in women with chronic lichen sclerosus of the vulva.

Standard

Health-related quality of life and patient-defined benefit of clobetasol 0.05% in women with chronic lichen sclerosus of the vulva. / Schwegler, J.; Schwarz, Jörg; Zu Eulenburg, Christine Gräfin; Blome, Christine; Henningsen, Maike; Mahner, Sven; Jänicke, Fritz; Augustin, Matthias; Wölber, Linn.

In: DERMATOLOGY, Vol. 223, No. 2, 2, 2011, p. 152-160.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Schwegler, J, Schwarz, J, Zu Eulenburg, CG, Blome, C, Henningsen, M, Mahner, S, Jänicke, F, Augustin, M & Wölber, L 2011, 'Health-related quality of life and patient-defined benefit of clobetasol 0.05% in women with chronic lichen sclerosus of the vulva.', DERMATOLOGY, vol. 223, no. 2, 2, pp. 152-160. <http://www.ncbi.nlm.nih.gov/pubmed/21997592?dopt=Citation>

APA

Schwegler, J., Schwarz, J., Zu Eulenburg, C. G., Blome, C., Henningsen, M., Mahner, S., Jänicke, F., Augustin, M., & Wölber, L. (2011). Health-related quality of life and patient-defined benefit of clobetasol 0.05% in women with chronic lichen sclerosus of the vulva. DERMATOLOGY, 223(2), 152-160. [2]. http://www.ncbi.nlm.nih.gov/pubmed/21997592?dopt=Citation

Vancouver

Schwegler J, Schwarz J, Zu Eulenburg CG, Blome C, Henningsen M, Mahner S et al. Health-related quality of life and patient-defined benefit of clobetasol 0.05% in women with chronic lichen sclerosus of the vulva. DERMATOLOGY. 2011;223(2):152-160. 2.

Bibtex

@article{d89d1d77bc924bf4a8b63e35346cfc8e,
title = "Health-related quality of life and patient-defined benefit of clobetasol 0.05% in women with chronic lichen sclerosus of the vulva.",
abstract = "This study investigates the health-related quality of life in patients with vulvar lichen sclerosus (LS) and the patient-defined therapeutic benefit of clobetasol.",
keywords = "Adult, Humans, Aged, Female, Middle Aged, Aged, 80 and over, Adolescent, Questionnaires, Young Adult, Emotions, Chronic Disease, Analysis of Variance, Patient Satisfaction, Quality of Life/*psychology, Anti-Inflammatory Agents/*therapeutic use, Clobetasol/*therapeutic use, Social Participation/psychology, Vulvar Lichen Sclerosus/*drug therapy/physiopathology/*psychology, Adult, Humans, Aged, Female, Middle Aged, Aged, 80 and over, Adolescent, Questionnaires, Young Adult, Emotions, Chronic Disease, Analysis of Variance, Patient Satisfaction, Quality of Life/*psychology, Anti-Inflammatory Agents/*therapeutic use, Clobetasol/*therapeutic use, Social Participation/psychology, Vulvar Lichen Sclerosus/*drug therapy/physiopathology/*psychology",
author = "J. Schwegler and J{\"o}rg Schwarz and {Zu Eulenburg}, {Christine Gr{\"a}fin} and Christine Blome and Maike Henningsen and Sven Mahner and Fritz J{\"a}nicke and Matthias Augustin and Linn W{\"o}lber",
year = "2011",
language = "English",
volume = "223",
pages = "152--160",
journal = "DERMATOLOGY",
issn = "1018-8665",
publisher = "S. Karger AG",
number = "2",

}

RIS

TY - JOUR

T1 - Health-related quality of life and patient-defined benefit of clobetasol 0.05% in women with chronic lichen sclerosus of the vulva.

AU - Schwegler, J.

AU - Schwarz, Jörg

AU - Zu Eulenburg, Christine Gräfin

AU - Blome, Christine

AU - Henningsen, Maike

AU - Mahner, Sven

AU - Jänicke, Fritz

AU - Augustin, Matthias

AU - Wölber, Linn

PY - 2011

Y1 - 2011

N2 - This study investigates the health-related quality of life in patients with vulvar lichen sclerosus (LS) and the patient-defined therapeutic benefit of clobetasol.

AB - This study investigates the health-related quality of life in patients with vulvar lichen sclerosus (LS) and the patient-defined therapeutic benefit of clobetasol.

KW - Adult

KW - Humans

KW - Aged

KW - Female

KW - Middle Aged

KW - Aged, 80 and over

KW - Adolescent

KW - Questionnaires

KW - Young Adult

KW - Emotions

KW - Chronic Disease

KW - Analysis of Variance

KW - Patient Satisfaction

KW - Quality of Life/psychology

KW - Anti-Inflammatory Agents/therapeutic use

KW - Clobetasol/therapeutic use

KW - Social Participation/psychology

KW - Vulvar Lichen Sclerosus/drug therapy/physiopathology/psychology

KW - Adult

KW - Humans

KW - Aged

KW - Female

KW - Middle Aged

KW - Aged, 80 and over

KW - Adolescent

KW - Questionnaires

KW - Young Adult

KW - Emotions

KW - Chronic Disease

KW - Analysis of Variance

KW - Patient Satisfaction

KW - Quality of Life/psychology

KW - Anti-Inflammatory Agents/therapeutic use

KW - Clobetasol/therapeutic use

KW - Social Participation/psychology

KW - Vulvar Lichen Sclerosus/drug therapy/physiopathology/psychology

M3 - SCORING: Journal article

VL - 223

SP - 152

EP - 160

JO - DERMATOLOGY

JF - DERMATOLOGY

SN - 1018-8665

IS - 2

M1 - 2

ER -